STAT

DECEMBER 20, 2023

But after two years of steady decline, 2024 might finally prove them right. Here are three major themes that we expect to drive the news in 2024 and determine whether biotech’s comeback is a sustainable trend or an interest-rate phenomenon.

317

317

Express Pharma

JANUARY 6, 2025

million in December 2024 from $4.53 million in November 2024. per cent decline in funding in December 2024, when compared with the $75 million in December 2023. 3Gen Consulting, Laurus Bio, and Orange Health reported the biggest funding rounds in December 2024, raising $22 million, $18.9 per cent to $69.8 per cent and 7.3

105

105

STAT

OCTOBER 30, 2024

The STAT Diversity and Inclusion Committee presents STAT’s 2024 Diversity and Inclusion Report. Here, we share the self-reported gender and racial/ethnic demographics of our staff from STAT’s inception in 2015 through 2023, as well as our 2023 new hire demographics. 

266

266

Express Pharma

DECEMBER 4, 2024

ACG Engineering, a division of ACG specialising in manufacturing solutions for the global pharmaceutical and nutraceutical industries, introduced its new ADAPT X feeder at CPhI & PMEC India 2024 in Delhi. Launching ADAPT X at PMEC 2024 allows us to demonstrate the transformative impact of this feeder to industry leaders,” he added.

Packaging 102

Packaging Pharmaceutical Companies Pharmaceutical Companies 102

Express Pharma

DECEMBER 19, 2024

CPHI & PMEC India 2024 concluded successfully at the India Expo Centre in Greater Noida, Delhi-NCR, from November 26th to 28th. The post India’s pharma industry showcased at CPHI & PMEC India 2024 appeared first on Express Pharma.

Pharmaceutical Manufacturing 104

Pharmaceutical Manufacturing 104

STAT

DECEMBER 26, 2023

Here are three CRISPR developments we’re watching in 2024: Continue to STAT+ to read the full story… The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

318

318

STAT

JANUARY 8, 2024

SAN FRANCISCO — Eric Tokat, biotech’s most prolific dealmaker, believes 2024 will be another strong year for acquisitions, driven by Big Pharma’s need to restock pipelines with medicines that can generate sales in the coming years. That’s not idle speculation.

344

344

STAT

DECEMBER 28, 2023

8-11, 2024 — setting the stage for the rest of the year in health, science, and medicine. The annual J.P. Morgan Healthcare Conference, the largest event of its kind, will take place in San Francisco, Jan. The event is a gathering space for investors, entrepreneurs, and others. 8 looking at what’s next in biotech.

277

277

PharmaVoice

OCTOBER 8, 2024

This year’s PharmaVoice 100 encompasses the industry’s ongoing revolutions and leaders who are not only navigating these changes, but at times, forging new paths for others to follow.

363

363

STAT

FEBRUARY 28, 2024

The 64 contestants whose discoveries and innovations have been selected for the 2024 edition of STAT Madness come from 50 institutions across the U.S. The teams include a Nobel laureate (Jennifer Doudna) and biotech big shots (Robert Langer and David Liu), but also up-and-comers.

347

347

The Pharmacist

JANUARY 28, 2025

Community Pharmacy Contractual Framework negotiations have now begun for the 2024/25 and 2025/26 funding agreements, the government has announced. Minister of state for care Stephen Kinnock […] The post BREAKING: Pharmacy contract negotiations begin for 2024/25 and 2025/26 appeared first on The Pharmacist.

Community Pharmacies 119

Community Pharmacies 119

STAT

JANUARY 11, 2024

Morgan Healthcare Conference, we discuss how a spate of deals and some intermittent sunshine seem to have brightened the outlook for biotech at the outset of 2024. Recording from the J.P. We also talk about the latest twist in the Sarepta Therapeutics saga, a ubiquitous dealmaker, and life on the party circuit. Read the rest…

254

254

STAT

DECEMBER 13, 2023

Pfizer said Wednesday that its 2024 profits would fall far below investor expectations, leading shares to tumble 7% in early trading. Pfizer said that its full-year revenue for 2024 should fall between $58.5 The reduced earnings numbers cap a difficult year for the drug giant. billion and $61.5

Vaccines 290

Vaccines 290

STAT

OCTOBER 24, 2024

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration. Read  Read an excerpt from each below.

Pharmaceutical Companies 250

Pharmaceutical Companies Pharmaceutical Companies 250

STAT

JANUARY 18, 2024

And what’s going to move markets in 2024? We also look ahead to the biggest biotech stories coming in 2024, including some major data readouts and a few pivotal FDA decisions. Why are rich biotechs cutting costs? Has JPM Week already worn off? Read the rest…

262

262

STAT

DECEMBER 26, 2023

On the policy side, the industry grappled with changing AI regulations, reimbursement woes, and device sterilization rules.

291

291

STAT

MARCH 3, 2025

The company indicated that the investigation began in 2017 and picked up in intensity in late 2024 and early 2025.    The SEC filing states that on Feb.   Continue to STAT+ to read the full story…

332

332

STAT

OCTOBER 7, 2024

“I’ve won 10 to 20 awards in the last 20 years, but never had a press conference with cameras and nothing like this,” Ruvkun, who along with Victor Ambros received the 2024 award in medicine or physiology on Monday, said at a press conference at Massachusetts General Hospital.

Medical Schools 317

Medical Schools Diabetes Hospitals 317

Express Pharma

NOVEMBER 25, 2024

The Pharmaceuticals and Medical Devices Bureau of India (PMBI), the implementing agency of the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) is participating in the 43rd India International Trade Fair (IITF) 2024.

104

104

STAT

AUGUST 8, 2024

The pharma giant on Thursday boosted its forecast for 2024 sales to a range of $45.4 Eli Lilly raised its full-year revenue guidance by $3 billion, driven by massive sales of its GLP-1-based diabetes and obesity drugs Mounjaro and Zepbound. billion to $46.6 billion from the previously guided range of $42.4 from the previously guided $13.50

Diabetes 287

Diabetes 287

STAT

OCTOBER 15, 2024

As Election Day 2024 gets closer, STAT’s First Opinion asked executives from leading biotech and pharmaceutical companies to reflect on how their industry is being portrayed in the presidential campaign — and what their hopes are for a new presidential administration.    With all eyes currently on the upcoming U.S.

Pharmaceutical Companies 243

Pharmaceutical Companies Pharmaceutical Companies Drug Development 243

STAT

MAY 20, 2024

STAT took a look at 20 large nonprofit health systems and found that all but four reported higher operating and net margins in the first three months of 2024 compared with the same period in 2023. Hospitals are seeing more patients and cutting down on the expensive contract labor they relied on during the Covid-19 pandemic.

Hospitals 273

Hospitals 273

Express Pharma

DECEMBER 8, 2024

In November 2024, the pharma and healthcare industry reported 95 deals worth $14.8 billion, compared to the last 12-month (November 2023 to October 2024) average of 102 deals worth $16.8 These three major deals contributed 25 per cent of the total deal value during November 2024.

103

103

STAT

FEBRUARY 29, 2024

Welcome to STAT Madness, a bracket-style contest to find the best innovation in science and medicine. Click on each matchup for a short summary of each school’s pioneering research. Then pick your favorites. Help us crown a champ! Previous Winners   |  Official Rules   |  FAQ

72

72

STAT

DECEMBER 4, 2024

Though health savings accounts, pharmacies, and major hospitals have all been attacked in 2024, a single data breach accounted for the vast majority of people’s data being exposed: Change Healthcare. Year after year, more Americans are affected by health care data breaches.

Hospitals 271

Hospitals 271

Express Pharma

NOVEMBER 26, 2024

Freudenberg, a worldwide technology business based in Germany, will attend CPhI & PMEC India 2024 on November 26-28, 2024. The post Freudenberg launches new products at CPhI & PMEC 2024 for Indian customers appeared first on Express Pharma. The booth, located in Hall No. 15 – No.

101

101

STAT

MARCH 19, 2025

In 2024, about 8% of pediatrics positions went unfilled , an increase from about 3% in 2023. On Friday, medical students around the U.S. will learn what residency program they have matched into. Match Day is not just momentous for those students, though.

Hospitals 238

Hospitals 238

STAT

DECEMBER 28, 2023

STAT’s taking a look at some of the recent health policy trends that states will start to implement in 2024. For most states, the new year means a new legislative session.

Drug Pricing 271

Drug Pricing Hospitals 271

STAT

JANUARY 15, 2025

According to data published this week by advisory Rock Health, startups using AI made up 37% of 2024’s digital health funding. Since OpenAI’s ChatGPT launched a wave of enthusiasm about the potential of AI, the technology has become a specific target for health care investors.

Hospitals 292

Hospitals 292

Express Pharma

OCTOBER 27, 2024

The post 9th Advanced GMP Workshop 2024 was organised by IPA appeared first on Express Pharma. IPA also announced the dates of the flagship pharma event of the year – the 10 th Global Pharmaceutical Quality Summit, which will be organised on February 27-28, 2025 in Mumbai.

Generic Medicine 104

Generic Medicine Process Improvement 104

Express Pharma

NOVEMBER 13, 2024

The 17th edition of CPHI & PMEC India, organised by Informa Markets in India, returns in an advanced format, scheduled from November 26-28, 2024, at the India Expo Centre, Greater Noida, Delhi-NCR. India’s pharma industry is on an impressive growth trajectory, expected to reach $65 billion by 2024 and to double to $130 billion by 2030.

Biosimilars 105

Biosimilars Pharmaceutical Manufacturing Hospitals 105

STAT

JANUARY 7, 2024

Greetings from JPM Week 2024! Want to stay on top of the science and politics driving biotech today?    Sign up to get our biotech newsletter in your inbox.

258

258

Express Pharma

FEBRUARY 13, 2025

DKSH reported core EBIT growth and strong cash conversion in 2024, with net sales reaching CHF 11.1 Butz said, I am delighted to report that in 2024, DKSH further advanced on its consistent path of growth, margin expansion and cash conversion. per cent in 2024. billion, representing a 4.0 Core EBIT rose to CHF 343.1

94

94

STAT

JANUARY 4, 2024

Morgan Healthcare Conference is upon us, bringing its frenetic meetings, crowded hallways, and hotel rooms so expensive that even the pharmaceutical industry complains about what a free market does to the prices of scarce goods.

327

327

PharmaVoice

DECEMBER 18, 2023

Advancements in cloud and AI technology will transform clinical trial efficiency and engagement.

340

340